← Evidence map

ArticleExpert opinion on pharmacotherapy2018

Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence.

Lingaku Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

59 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29757017